Loading live market data…

Cytokinetics, Incorporated

NASDAQ:CYTK

$81.93 USD

-$0.31 (-0.38%)

Volume
1.44M
Average Volume
2.62M
Market Capitalization
$10.19B
P/E Ratio
-12.00
Dividend Yield
0.00%
Price Target
$108.00
Year High
$88.31
Year Low
$32.89
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$4.21

CYTK Estimated and Actual Revenue by Quarter

CYTK Estimated and Actual EPS by Quarter

CYTK Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 8 -78.59M -30.1M -44.69M -78.59M -30.1M -44.69M
2028-09-30 6 -72.83M -27.89M -41.42M -72.83M -27.89M -41.42M
2028-06-30 5 -67.5M -25.85M -38.38M -67.5M -25.85M -38.38M
2028-03-31 5 -62.55M -23.96M -35.57M -62.55M -23.96M -35.57M
2027-12-31 6 -270.38M -103.55M -153.75M -270.38M -103.55M -153.75M
2027-09-30 6 -191.68M -73.41M -109M -191.68M -73.41M -109M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 8 -159.83M -46.31M -80.47M 247.99M 647.51M 368.21M
2028-09-30 6 -624.79M -181.05M -314.58M 229.82M 600.08M 341.24M
2028-06-30 5 -275.39M -79.8M -138.66M 212.99M 556.12M 316.24M
2028-03-31 5 -333.44M -96.62M -167.89M 197.38M 515.39M 293.08M
2027-12-31 6 -221.57M -64.21M -111.56M 853.16M 2.23B 1.27B
2027-09-30 6 -297.47M -86.2M -149.78M 604.84M 1.58B 898.07M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 8 30.1M 78.59M 44.69M 5 -1.29653 -0.37571 -0.6528
2028-09-30 6 27.89M 72.83M 41.42M 10 -5.06833 -1.46871 -2.5519
2028-06-30 5 25.85M 67.5M 38.38M 7 -2.23396 -0.64736 -1.1248
2028-03-31 5 23.96M 62.55M 35.57M 5 -2.70487 -0.78382 -1.3619
2027-12-31 6 103.55M 270.38M 153.75M 4 -1.79742 -0.52086 -0.905
2027-09-30 6 73.41M 191.68M 109M 8 -2.41311 -0.69928 -1.215